APA

Lobell R. B., Omer C. A., Abrams M. T., Bhimnathwala H. G., Brucker M. J., Buser C. A., Davide J. P., deSolms S. J., Dinsmore C. J., Ellis-Hutchings M. S., Kral A. M., Liu D., Lumma W. C., Machotka S. V., Rands E., Williams T. M., Graham S. L., Hartman G. D., Oliff A. I., Heimbrook D. C. & Kohl N. E. (20020110). Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. : Cancer research.

Chicago

Lobell R B, Omer C A, Abrams M T, Bhimnathwala H G, Brucker M J, Buser C A, Davide J P, deSolms S J, Dinsmore C J, Ellis-Hutchings M S, Kral A M, Liu D, Lumma W C, Machotka S V, Rands E, Williams T M, Graham S L, Hartman G D, Oliff A I, Heimbrook D C and Kohl N E. 20020110. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. : Cancer research.

Harvard

Lobell R. B., Omer C. A., Abrams M. T., Bhimnathwala H. G., Brucker M. J., Buser C. A., Davide J. P., deSolms S. J., Dinsmore C. J., Ellis-Hutchings M. S., Kral A. M., Liu D., Lumma W. C., Machotka S. V., Rands E., Williams T. M., Graham S. L., Hartman G. D., Oliff A. I., Heimbrook D. C. and Kohl N. E. (20020110). Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. : Cancer research.

MLA

Lobell R B, Omer C A, Abrams M T, Bhimnathwala H G, Brucker M J, Buser C A, Davide J P, deSolms S J, Dinsmore C J, Ellis-Hutchings M S, Kral A M, Liu D, Lumma W C, Machotka S V, Rands E, Williams T M, Graham S L, Hartman G D, Oliff A I, Heimbrook D C and Kohl N E. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. : Cancer research. 20020110.